Couverture de Episode 23 - Assessing Risk and Knowing When to Act

Episode 23 - Assessing Risk and Knowing When to Act

Episode 23 - Assessing Risk and Knowing When to Act

Écouter gratuitement

Voir les détails

Offres de saison | 0,99 € par mois pendant les 3 premiers mois

5,99 €/mois par la suite. Des conditions s’appliquent. Annulation mensuelle possible.

This module examines structured risk assessment as the foundation for goal-directed management of pulmonary arterial hypertension (PAH), emphasizing that clinical stability is not synonymous with low-risk status. It reviews validated risk-stratification approaches and the integration of functional capacity, biomarkers, imaging, and hemodynamics to assess prognosis and treatment response. The module emphasizes routine reassessment and timely treatment modification when patients fail to achieve or maintain low-risk status, while also incorporating treatment burden and patient preferences into shared decision-making.

Visit the link in our bio to earn FREE AMA, ABS, ANCC or ACPE credit!

adbl_web_anon_alc_button_suppression_t1
Aucun commentaire pour le moment